Euroclear
  • Catching the next wave of OTC derivative margining

    The initial launch of the new regime for margin requirements for non-cleared derivatives passed on September 1. This first wave affected those firms with the largest presence in the market for both initial and variation margins under the new regulations.

    • 08 Feb 2017
  • Buyside appetite in OTC derivatives remains undiminished

    Like most major regulatory changes, the introduction of new margin, collateral and capital requirements for non-cleared OTC derivatives has been subject to delay as regulators finalise the details and dealers are struggling with their implementation. With its global start date already having been delayed from Q3 2015 to 2016, Europe is now pushing back further, most likely to Q2 1017.

    • 08 Nov 2016
  • Changes to OTC derivatives margining and what it means for the buy-side

    As buyside firms look at their options for sourcing, mobilising and protecting collateral assets to be used as margin, whether for cleared or non-cleared OTC derivatives instruments, they very soon come up against problems of fragmentation.

    • 14 Oct 2016
  • A time for change in the non-cleared OTC derivatives industry

    To bring good luck in marriage, an English bride is often advised to wear “something old, something new, something borrowed, something blue” on her wedding day. Some derivatives contracts last longer than marriages these days, but relationships between the counterparties are no longer trusted to luck. From September, a stricter regulatory framework is being introduced for bilateral OTC derivatives transactions, including rules that ensure the assets of one counterparty are unaffected by default of the other, thus avoiding being tied together, “for richer, for poorer”.

    • 15 Jun 2016
  • The origins of enterprise-wide collateral management

    To date, the new regulatory framework for bilateral OTC swaps has received less attention than other aspects of the post-crisis derivatives reform agenda. But its impact is likely to be just as far-reaching.

    • 06 Apr 2016

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 13 Mar 2017
1 JPMorgan 94,925.33 384 8.39%
2 Citi 87,531.58 331 7.74%
3 Bank of America Merrill Lynch 84,341.49 288 7.46%
4 Barclays 75,288.19 241 6.66%
5 Goldman Sachs 68,504.71 208 6.06%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 16 May 2017
1 Deutsche Bank 19,381.65 47 8.82%
2 Bank of America Merrill Lynch 18,968.25 36 8.63%
3 HSBC 18,103.95 50 8.24%
4 BNP Paribas 8,911.57 55 4.05%
5 SG Corporate & Investment Banking 8,885.00 54 4.04%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 8,714.26 35 8.36%
2 UBS 8,283.47 33 7.95%
3 Goldman Sachs 7,736.57 37 7.42%
4 Citi 6,897.11 46 6.62%
5 Bank of America Merrill Lynch 6,215.31 24 5.96%